Anavex Files Early AD IND Application
Anavex Life Sciences filed an IND for ANAVEX2-73 targeting early Alzheimer's disease. The company implemented a disciplined data-driven strategy focusing on FDA engagement.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day